Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Valeritas Holdings Inc. (VLRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
04/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
04/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
04/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
04/02/2020 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Compl...
Docs: "Amendment No. 2 to Asset Purchase Agreement"
03/31/2020 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/30/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/30/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/30/2020 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/20/2020 8-K Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits
Docs: "Valeritas Receives Court Approval of Sale of Business to Zealand Pharma Will Result in the Retention of the Vast Majority of Valeritas Employees Enables Continued Production and Distribution of V-Go® Wearable Insulin Delivery Device"
03/18/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No.1 to Asset Purchase Agreement"
03/16/2020 8-K Quarterly results
03/09/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
02/28/2020 8-K Quarterly results
02/14/2020 8-K Quarterly results
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 8-K Quarterly results
01/10/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/23/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/23/2019 8-K Quarterly results
12/20/2019 8-K Quarterly results
12/11/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Corporate Presentation"
12/09/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting Presentation of data sets for both 40mg and 76mg of CBD Isolate Delivered via h-Patch™ System"
12/09/2019 GN Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting
11/20/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
11/15/2019 8-K Quarterly results
11/15/2019 GN Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage
11/12/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/12/2019 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy